FIELD: medicine.
SUBSTANCE: group of inventions refers to new methods of treating and suppressing the tumour growth, specifically malignant solid tumours by administering an effective amount of adenosine aminase conjugated with a non-antigen polymer for the purpose of the tissue adenosine and deoxyadenosine level recovery.
EFFECT: post-therapeutic tumour shows a reduced volume or a reduced growth rate.
19 cl, 5 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STABLE RECOMBINANT ADENOSINE DEAMINASE | 2008 |
|
RU2486246C2 |
| RELEASED POLYMER CONJUGATES BASED ON ALIPHATIC BIOLOGICALLY DECOMPOSING AGENTS | 2003 |
|
RU2324702C2 |
| SYNTHESIS OF POLYMER CONJUGATES OF INDOLOCARBAZOLE COMPOUNDS | 2009 |
|
RU2532341C2 |
| COMPOSITION FOR WASHING CLOTHES CONTAINING DYES | 2012 |
|
RU2598853C2 |
| NOVEL POLYMER-BASED HYDROTROPES FOR HYDROPHOBIC DRUG DELIVERY | 2014 |
|
RU2676680C2 |
| INTERFERON CONJUGATES | 1997 |
|
RU2180595C2 |
| MODIFIED NUCLEOSIDE, NUCLEOTIDE AND NUCLEIC ACID COMPOSITIONS | 2012 |
|
RU2649364C2 |
| POLYGLUTAMATE-AMINO ACID CONJUGATES AND METHODS | 2006 |
|
RU2472812C2 |
| METHOD OF PRODUCING POLYMER CONJUGATES | 2006 |
|
RU2401283C2 |
| PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING GROWTH HORMONE-ASSOCIATED DISEASES IN HUMANS | 2014 |
|
RU2689336C2 |
